NRIX insider trades & Congress trades
Nurix Therapeutics, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 21 open-market insider transactions in Nurix Therapeutics, Inc. (NRIX) (0 purchases with code P and 21 sales with code S), the most recent on November 4, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 15 sales by 4 ($1.71M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | van Houte Hans | Chief Financial Officer | Sell | 3,300 | $15.38 | $51K | – |
| Nov 4, 2026 | van Houte Hans | Chief Financial Officer | Sell | 1,469 | $16.20 | $24K | – |
| Nov 3, 2026 | Ring Christine | Chief Legal Officer | Sell | 6,113 | $25.83 | $158K | – |
| Nov 2, 2026 | Hansen Gwenn | Chief Scientific Officer | Sell | 1,452 | $26.80 | $39K | – |
| Nov 2, 2026 | Ring Christine | Chief Legal Officer | Sell | 9,527 | $25.74 | $245K | – |
| Nov 2, 2026 | Ring Christine | Chief Legal Officer | Sell | 1,075 | $26.76 | $29K | – |
| Oct 30, 2026 | Hansen Gwenn | Chief Scientific Officer | Sell | 3,957 | $26.28 | $104K | – |
| Oct 30, 2026 | Ring Christine | Chief Legal Officer | Sell | 3,957 | $26.28 | $104K | – |
| Oct 30, 2026 | van Houte Hans | Chief Financial Officer | Sell | 2,834 | $26.28 | $74K | – |
| Oct 15, 2026 | Hansen Gwenn | Chief Scientific Officer | Sell | 1,452 | $25.00 | $36K | – |
| Oct 14, 2026 | Gregory Julia P | – | Sell | 22,583 | $23.40 | $529K | – |
| Oct 2, 2026 | Ring Christine | Chief Legal Officer | Sell | 5,786 | $23.19 | $134K | – |
| Sep 2, 2026 | Ring Christine | Chief Legal Officer | Sell | 5,387 | $25.69 | $138K | −0.1% |
| Sep 2, 2026 | Ring Christine | Chief Legal Officer | Sell | 400 | $26.64 | $11K | −0.1% |
| Sep 1, 2026 | Hansen Gwenn | Chief Scientific Officer | Sell | 1,452 | $25.47 | $37K | −0.1% |
| Aug 5, 2026 | Hansen Gwenn | Chief Scientific Officer | Sell | 4,356 | $25.00 | $109K | +0.0% |
| Aug 4, 2026 | van Houte Hans | Chief Financial Officer | Sell | 1,794 | $23.89 | $43K | +0.0% |
| Aug 4, 2026 | van Houte Hans | Chief Financial Officer | Sell | 2,967 | $24.65 | $73K | +0.0% |
| Aug 4, 2026 | Hansen Gwenn | Chief Scientific Officer | Sell | 1,500 | $23.87 | $36K | +0.0% |
| Aug 4, 2026 | Hansen Gwenn | Chief Scientific Officer | Sell | 2,611 | $24.64 | $64K | +0.0% |
| Aug 3, 2026 | Ring Christine | Chief Legal Officer | Sell | 16,589 | $23.05 | $382K | +0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.